Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Dynavax Technologies Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
Dynavax Technologies şirketinin toplam hissedar öz sermayesi $642.8M ve toplam borcu $223.3M olup, bu da borç-öz sermaye oranını 34.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $1.0B ve $373.5M dir.
Anahtar bilgiler
34.7%
Borç/özkaynak oranı
US$223.27m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$735.61m |
| Eşitlik | US$642.85m |
| Toplam yükümlülükler | US$373.47m |
| Toplam varlıklar | US$1.02b |
Son finansal sağlık güncellemeleri
Is Dynavax Technologies (NASDAQ:DVAX) Weighed On By Its Debt Load?
Jul 12
Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12Recent updates
Dynavax Technologies: Slow And Steady Wins The Race
Sep 05Dynavax Technologies: A Two Trick Pony Operating With A Single Trick
Aug 23Some May Be Optimistic About Dynavax Technologies' (NASDAQ:DVAX) Earnings
Aug 14Is Dynavax Technologies (NASDAQ:DVAX) Weighed On By Its Debt Load?
Jul 12Lacklustre Performance Is Driving Dynavax Technologies Corporation's (NASDAQ:DVAX) Low P/S
May 22Dynavax: HEPLISAV-B Growth Up, Pipeline Uncertain
May 10Dynavax: Holding Firm Despite Its Missing Cash Cow
Mar 23Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06Dynavax Technologies Corporation's (NASDAQ:DVAX) Business And Shares Still Trailing The Industry
Jan 31These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02Improved Earnings Required Before Dynavax Technologies Corporation (NASDAQ:DVAX) Shares Find Their Feet
Jun 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Clover, Dynavax COVID-19 vaccine gets EU GMP certificate
Sep 20Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12The Alphavaxers: Dynavax And Novavax, 2 Quarters On
Aug 22Dynavax up 8% after raising full-year guidance for key adjuvant product, Q2 beats
Aug 04Are Investors Undervaluing Dynavax Technologies Corporation (NASDAQ:DVAX) By 41%?
Jun 03Dynavax: Evolving Endemic Situation Adds To Its Risk
May 23Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest
May 12Dynavax Technologies (NASDAQ:DVAX) Could Easily Take On More Debt
May 10Dynavax Technologies: Full Speed Ahead
Mar 01Here's Why Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt Responsibly
Jan 28Dynavax: A Coronavirus Growth Story
Jan 17Is Dynavax Technologies Corporation (NASDAQ:DVAX) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 18The Momentum Investor: Spotlight On Dynavax Technologies
Oct 25Dynavax And TLR Biology: Long-Delayed But Outstanding Success
Oct 16These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Reasonably Well
Oct 02Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: DVAX 'nin kısa vadeli varlıkları ( $882.0M ) kısa vadeli yükümlülüklerini ( $62.2M ) aşıyor.
Uzun Vadeli Yükümlülükler: DVAX şirketinin kısa vadeli varlıkları ( $882.0M ) uzun vadeli yükümlülüklerini ( $311.3M ) aşmaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: DVAX şirketinin toplam borcundan daha fazla nakiti var.
Borcun Azaltılması: DVAX 'nin borç/öz sermaye oranı son 5 yılda 1668.3% seviyesinden 34.7% seviyesine düştü.
Borç Kapsamı: DVAX 'nin borcu işletme nakit akışı ( 17.4% ) tarafından iyi bir şekilde karşılanmıyor.
Faiz Kapsamı: DVAX şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.